Cannabis stocks are getting a ton of attention after Tilray (TLRY) has surged to record highs. This rally has attracted negative attention and we are closely monitoring how the sector trades from here.
Today, we want to highlight 3 Canadian cannabis producers that are generating more revenue than Tilray and that are worth watching.
Canopy Growth: A Leading Global Cannabis Company
Canopy Growth (WEED.TO) (CGC) is by far the largest and most diverse licensed Canadian medical marijuana producer. The company is comprised of several wholly‑owned subsidiaries and has increased its reach by making investments and acquisitions of companies all over the globe.
Last month, the Canadian cannabis producer received a $5 billion investment from Constellation Brands (STZ) and this was served as a major catalyst for the company as well as the sector. Canopy plans to use to the capital to expand its global market position and make investments in emerging legal cannabis markets.
Canopy Growth was the first publicly traded licensed Canadian medical marijuana producer and has been. The company has a greater breadth of multi-site management than any other cannabis firm in the world. Canopy currently has cannabis operations in 12 countries on 5 continents.
With more than $5 billion in cash on hand, the company is well positioned to significantly increase market share through acquisitions. We expect to see Canopy further expand its presence across the globe and see continued growth for years to come.
Although Tilray has been stealing the headlines due to the recent price movements, Canopy possesses some of the most attractive growth prospects and we expect the company to continue to be a leader for years to come.
An Emerging Global Cannabis Leader
Aurora Cannabis Inc. (ACB.V) (ACBFF) has been making waves in the global marijuana industry and is an industry leader. From Australia to Germany, this Canadian licensed producer has significantly increased its market share and is levered to new legal cannabis markets across the globe.
Earlier this month, Aurora announced the acquisition of ICC Labs (ICC.V) (ICCLF) which is a leading South American cannabis company. ICC Labs has a leading position in Uruguay and this acquisition provides significant leverage to a burgeoning Latin American market. Earlier this year, Aurora announced a significant partnership and investment in The Green Organic Dutchman (TGOD.TO) (TGODF) and has some very attractive growth prospects.
Last year, Aurora acquired Pedanios GmbH which has been importing, exporting, and distributing medical cannabis into and within the EU since December 2015. The global cannabis company has attractive leverage to several of the most exciting markets in the world and we are monitoring how the team continues to execute.
Aurora has a very strong balance sheets and is levered to several emerging growth trends throughout the world. We are favorable on the continued execution and investors need to be monitoring this one.
Aphria Continues to Drive Value
2018 has been a banner year for Aphria Inc. (APH.TO) (APHQF), a leading global cannabis company, and we are monitoring how the team executes from here. The company has made several accretive acquisitions this year and is in the middle of a major growth cycle. Aphria is led by a top management team and is in the middle of a major expansion.
The Canadian cannabis produce has secured distribution agreements in Canada for the recreational market and has formed strategic relationships with companies like Emblem Corp. (EMC.V) (EMMBF). Last month, Aphria signed a manufacturer’s representative agreement with We Grow BC Ltd., a Vancouver-based licensed producer of premium cannabis, to become the exclusive sales representative across Canada. The agreement adds a second brand of premium B.C.-bud to be sold alongside Aphria’s expanding portfolio of adult-use brands, which includes celebrated B.C.-bud from Broken Coast Cannabis through the company’s coast-to-coast sales distribution network.
Aphria’s sales team is supported by Great North Distributors, a subsidiary of Southern Glazer’s Wine & Spirits as Aphria’s exclusive cannabis representative in Canada, providing 100% coverage of all cannabis retailers, whether provincially or privately operated, from the first day of legal adult-use sales. We are favorable on the leverage to the Canadian market as well as the international opportunity.
Going forward, we expect fundamentals to significantly improve as new production comes online and international markets mature. Aphria is well positioned to capitalize on what has become a global opportunity and investors need to be watching this one.